The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maeda, H.
Right arrow Articles by Shiraishi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maeda, H.
Right arrow Articles by Shiraishi, A.

The Journal of Immunology, Vol 156, Issue 1 73-78, Copyright © 1996 by American Association of Immunologists

ARTICLES

TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice

H Maeda and A Shiraishi
Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

In previous reports, we showed that tumor-derived TGF-beta induced overproduction of IL-10, and these suppressive cytokines caused macrophage suppression in EL4-bearing mice. Proliferation of T cells from EL-4, but not IL-2, whereas T cells from normal mice were responsive to IL-2. A balance between Th1- and Th2-type cytokine production in EL4-T in response to anti-CD3 Ab or phorbor myristate acetate plus A23187 shifted toward the Th2 dominant pattern. The prevention of TGF-beta and IL-10 activates in vivo by administration of anti-IL-10 Ab (anti-IL-10) or anti TGF-beta Ab (anti-TGF-beta) resulted in the reduction in EL4-T of both IL-4 dependent proliferation and Th2- dominant cytokine production induced by anti-CD-3 stimulation. In addition, the anti-TGF-beta treatment resulted in complete restoration in EL4-T of suppressed IL-2 responsiveness, IL-2R expression, and Th1- type cytokine production, whereas the anti-IL-10 treatment produced partial recovery. These results lead us to conclude that TGF-beta drives the shift in the Th1/Th2 balance toward Th2 via IL-10-mediated development of the Th2 responses and via inhibition of the Th1-type responses directly in EL4-bearing mice.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. Gil-Guerrero, J. Dotor, I. L. Huibregtse, N. Casares, A. B. Lopez-Vazquez, F. Rudilla, J. I. Riezu-Boj, J. Lopez-Sagaseta, J. Hermida, S. Van Deventer, et al.
In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-{beta}1
J. Immunol., July 1, 2008; 181(1): 126 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. A. Teicher
Transforming Growth Factor-{beta} and the Immune Response to Malignant Disease
Clin. Cancer Res., November 1, 2007; 13(21): 6247 - 6251.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M.-L. Cheng, H.-W. Chen, J.-P. Tsai, Y.-P. Lee, Y.-C. Shih, C.-M. Chang, and C.-C. Ting
Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}
J. Leukoc. Biol., May 1, 2006; 79(5): 1033 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Rohrer, A. L. Barsoum, and J. H. Coggin Jr.
Identification of Oncofetal Antigen/Immature Laminin Receptor Protein Epitopes That Activate BALB/c Mouse OFA/iLRP-Specific Effector and Regulatory T Cell Clones.
J. Immunol., March 1, 2006; 176(5): 2844 - 2856.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sharma, L. Zhu, S. C. Yang, L. Zhang, J. Lin, S. Hillinger, B. Gardner, K. Reckamp, R. M. Strieter, M. Huang, et al.
Cyclooxygenase 2 Inhibition Promotes IFN-{gamma}-Dependent Enhancement of Antitumor Responses
J. Immunol., July 15, 2005; 175(2): 813 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. K. Andersson, M. Chaduvula, S. E. Atkinson, S. Khanolkar-Young, S. Jain, L. Suneetha, S. Suneetha, and D. N. J. Lockwood
Effects of Prednisolone Treatment on Cytokine Expression in Patients with Leprosy Type 1 Reactions
Infect. Immun., June 1, 2005; 73(6): 3725 - 3733.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y.-J. Kim, T. M. Stringfield, Y. Chen, and H. E. Broxmeyer
Modulation of cord blood CD8+ T-cell effector differentiation by TGF-{beta}1 and 4-1BB costimulation
Blood, January 1, 2005; 105(1): 274 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Beckebaum, X. Zhang, X. Chen, Z. Yu, A. Frilling, G. Dworacki, H. Grosse-Wilde, C. E. Broelsch, G. Gerken, and V. R. Cicinnati
Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets
Clin. Cancer Res., November 1, 2004; 10(21): 7260 - 7269.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Monti, B. E. Leone, A. Zerbi, G. Balzano, S. Cainarca, V. Sordi, M. Pontillo, A. Mercalli, V. Di Carlo, P. Allavena, et al.
Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell
J. Immunol., June 15, 2004; 172(12): 7341 - 7349.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Sredni, M. Weil, G. Khomenok, I. Lebenthal, S. Teitz, Y. Mardor, Z. Ram, A. Orenstein, A. Kershenovich, S. Michowiz, et al.
Ammonium Trichloro(dioxoethylene-o,o')tellurate (AS101) Sensitizes Tumors to Chemotherapy by Inhibiting the Tumor Interleukin 10 Autocrine Loop
Cancer Res., March 1, 2004; 64(5): 1843 - 1852.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Monteleone, J. Mann, I. Monteleone, P. Vavassori, R. Bremner, M. Fantini, G. Del Vecchio Blanco, R. Tersigni, L. Alessandroni, D. Mann, et al.
A Failure of Transforming Growth Factor-{beta}1 Negative Regulation Maintains Sustained NF-{kappa}B Activation in Gut Inflammation
J. Biol. Chem., February 6, 2004; 279(6): 3925 - 3932.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. De Bosscher, W. Vanden Berghe, and G. Haegeman
The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression
Endocr. Rev., August 1, 2003; 24(4): 488 - 522.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Nakamori, M. Iwahashi, M. Nakamura, K. Ueda, X. Zhang, and H. Yamaue
Intensification of Antitumor Effect by T Helper 1-dominant Adoptive Immunogene Therapy for Advanced Orthotopic Colon Cancer
Clin. Cancer Res., June 1, 2003; 9(6): 2357 - 2365.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. S. Yang and E. C. Lattime
Tumor-induced Interleukin 10 Suppresses the Ability of Splenic Dendritic Cells to Stimulate CD4 and CD8 T-Cell Responses
Cancer Res., May 1, 2003; 63(9): 2150 - 2157.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. X. Zhu, S. Sharma, B. Gardner, B. Escuadro, K. Atianzar, D. P. Tashkin, and S. M. Dubinett
IL-10 Mediates Sigma1 Receptor-Dependent Suppression of Antitumor Immunity
J. Immunol., April 1, 2003; 170(7): 3585 - 3591.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Mashino, N. Sadanaga, F. Tanaka, M. Ohta, H. Yamaguchi, and M. Mori
Effective Strategy of Dendritic Cell-based Immunotherapy for Advanced Tumor-bearing Hosts: the Critical Role of Th1-dominant Immunity
Mol. Cancer Ther., August 1, 2002; 1(10): 785 - 794.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
F. H. Igney and P. H. Krammer
Immune escape of tumors: apoptosis resistance and tumor counterattack
J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. D. Brown, B. Pope, A. Murray, W. Esdale, D. M. Sze, J. Gibson, P. J. Ho, D. Hart, and D. Joshua
Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta 1 and interleukin-10
Blood, November 15, 2001; 98(10): 2992 - 2998.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. BAGOT, M. NIKOLOVA, F. SCHIRM-CHABANETTE, J. WECHSLER, L. BOUMSELL, and A. BENSUSSAN
Crosstalk between Tumor T Lymphocytes and Reactive T Lymphocytes in Cutaneous T Cell Lymphomas
Ann. N.Y. Acad. Sci., September 1, 2001; 941(1): 31 - 38.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B.-C. Sheu, R.-H. Lin, H.-C. Lien, H.-N. Ho, S.-M. Hsu, and S.-C. Huang
Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer
J. Immunol., September 1, 2001; 167(5): 2972 - 2978.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. S. Ostlie, P. I. Karachunski, W. Wang, C. Monfardini, M. Kronenberg, and B. M. Conti-Fine
Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis
J. Immunol., April 15, 2001; 166(8): 4853 - 4862.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-H. Sonoda, D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein
NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance
J. Immunol., January 1, 2001; 166(1): 42 - 50.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Wang, R. J. Homer, Q. Chen, and J. A. Elias
Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation
J. Immunol., October 1, 2000; 165(7): 4051 - 4061.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Kaji, M. Kobayashi, R. B Pollard, and F. Suzuki
Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection
J. Leukoc. Biol., August 1, 2000; 68(2): 180 - 186.
[Abstract] [Full Text]

Home page
 BloodHome page
E. Poszepczynska, M. Bagot, H. Echchakir, D. Martinvalet, M. Ramez, D. Charue, L. Boumsell, and A. Bensussan
Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma
Blood, August 1, 2000; 96(3): 1056 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. H. Little, G. M. Georgiou, A. Marceglia, H. Ogedgebe, R. E. Cone, and D. Mazza
Measurement of T-Cell-Derived Antigen Binding Molecules and Immunoglobulin G Specific to Candida albicans Mannan in Sera of Patients with Recurrent Vulvovaginal Candidiasis
Infect. Immun., July 1, 2000; 68(7): 3840 - 3847.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. X. Zhu, S. Sharma, M. Stolina, B. Gardner, M. D. Roth, D. P. Tashkin, and S. M. Dubinett
{Delta}-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway
J. Immunol., July 1, 2000; 165(1): 373 - 380.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. I. Karachunski, N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine
Absence of IFN-{gamma} or IL-12 Has Different Effects on Experimental Myasthenia Gravis in C57BL/6 Mice
J. Immunol., May 15, 2000; 164(10): 5236 - 5244.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Stolina, S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al.
Specific Inhibition of Cyclooxygenase 2 Restores Antitumor Reactivity by Altering the Balance of IL-10 and IL-12 Synthesis
J. Immunol., January 1, 2000; 164(1): 361 - 370.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A.G.S. Buggins, N. Lea, J. Gaken, D. Darling, F. Farzaneh, G.J. Mufti, and W.J.R. Hirst
Effect of Costimulation and the Microenvironment on Antigen Presentation by Leukemic Cells
Blood, November 15, 1999; 94(10): 3479 - 3490.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. W. v. Ginkel, S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee
Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-{beta}1 Knockout Mice
J. Immunol., August 15, 1999; 163(4): 1951 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Bellone, A. Turletti, E. Artusio, K. Mareschi, A. Carbone, D. Tibaudi, A. Robecchi, G. Emanuelli, and U. Rodeck
Tumor-Associated Transforming Growth Factor-{beta} and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients
Am. J. Pathol., August 1, 1999; 155(2): 537 - 547.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Matsui, J. D. Ahlers, A. O. Vortmeyer, M. Terabe, T. Tsukui, D. P. Carbone, L. A. Liotta, and J. A. Berzofsky
A Model for CD8+ CTL Tumor Immunosurveillance and Regulation of Tumor Escape by CD4 T Cells Through an Effect on Quality of CTL
J. Immunol., July 1, 1999; 163(1): 184 - 193.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Seo, Y. Tokura, M. Takigawa, and K. Egawa
Depletion of IL-10- and TGF-{beta}-Producing Regulatory {gamma}{delta} T Cells by Administering a Daunomycin-Conjugated Specific Monoclonal Antibody in Early Tumor Lesions Augments the Activity of CTLs and NK Cells
J. Immunol., July 1, 1999; 163(1): 242 - 249.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. W. Rohrer, A. L. Barsoum, D. L. Dyess, J. A. Tucker, and J. H. Coggin Jr.
Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes
J. Immunol., June 1, 1999; 162(11): 6880 - 6892.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Zhang, F. H. Straus, and L. J. DeGroot
Effective Genetic Therapy of Established Medullary Thyroid Carcinomas with Murine Interleukin-2: Dissemination and Cytotoxicity Studies in a Rat Tumor Model
Endocrinology, May 1, 1999; 140(5): 2152 - 2158.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
N. Sharma, J. Luo, D. A. Kirschmann, Y. O'Malley, M. E. C. Robbins, E. T. Akporiaye, D. M. Lubaroff, P. M. Heidger, and M. J. C. Hendrix
A Novel Immunological Model for the Study of Prostate Cancer
Cancer Res., May 1, 1999; 59(10): 2271 - 2276.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Won, H. Kim, E. J. Park, Y. Hong, S.-J. Kim, and Y. Yun
Tumorigenicity of Mouse Thymoma Is Suppressed by Soluble Type II Transforming Growth Factor {beta} Receptor Therapy
Cancer Res., March 1, 1999; 59(6): 1273 - 1277.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Pardoux, X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib
Downregulation of Interleukin-12 (IL-12) Responsiveness in Human T Cells by Transforming Growth Factor-beta : Relationship With IL-12 Signaling
Blood, March 1, 1999; 93(5): 1448 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
F. M. Omer and E. M. Riley
Transforming Growth Factor beta  Production Is Inversely Correlated with Severity of Murine Malaria Infection
J. Exp. Med., July 1, 1998; 188(1): 39 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Kobayashi, H. Kobayashi, R. B. Pollard, and F. Suzuki
A Pathogenic Role of Th2 Cells and Their Cytokine Products on the Pulmonary Metastasis of Murine B16 Melanoma
J. Immunol., June 15, 1998; 160(12): 5869 - 5873.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. MacDonald, R. M. Maizels, R. A. Lawrence, I. Dransfield, and J. E. Allen
Requirement for In Vivo Production of IL-4, But Not IL-10, in the Induction of Proliferative Suppression by Filarial Parasites
J. Immunol., April 15, 1998; 160(8): 4124 - 4132.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. S. MacDonald, R. M. Maizels, R. A. Lawrence, I. Dransfield, and J. E. Allen
Requirement for In Vivo Production of IL-4, But Not IL-10, in the Induction of Proliferative Suppression by Filarial Parasites
J. Immunol., February 1, 1998; 160(3): 1304 - 1312.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani
Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells
Endocrinology, October 1, 1997; 138(10): 4160 - 4166.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. S. Douglas, R. J. Capocasale, R. J. Lamb, P. C. Nowell, and J. S. Moore
Chronic Lymphocytic Leukemia B Cells Are Resistant to the Apoptotic Effects of Transforming Growth Factor-beta
Blood, February 1, 1997; 89(3): 941 - 947.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.